Drug Shortage Report for MINT-OLANZAPINE ODT
| Report ID | 108298 |
| Drug Identification Number | 02436973 |
| Brand name | MINT-OLANZAPINE ODT |
| Common or Proper name | Olanzapine |
| Company Name | MINT PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | OLANZAPINE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | ORAL |
| Packaging size | 30 count Blisters |
| ATC code | N05AH |
| ATC description | ANTIPSYCHOTICS |
| Reason for shortage | Requirements related to complying with good manufacturing practices. |
| Anticipated start date | |
| Actual start date | 2020-03-09 |
| Estimated end date | |
| Actual end date | 2021-01-15 |
| Shortage status | Resolved |
| Updated date | 2021-01-16 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.